Docoh
Loading...

SWKH Swk

Press releases

From Benzinga Pro
SWK Holdings Confirms Receipt of Non-Binding Proposal from Carlson Capital L.P.
24 Nov 21
Press Releases
DALLAS, Nov. 24, 2021 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) (the "Company" or "SWK") confirmed that on November 23, 2021, it received a non-binding proposal from funds managed by Carlson
Enteris BioPharma Publishes Article Examining the Growing Utilization of the 505(b)(2) Regulatory Pathway in Drug Development
17 Nov 21
Press Releases
BOONTON, N.J., Nov. 17, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK
SWK Holdings Corporation Announces Financial Results for Third Quarter 2021
12 Nov 21
Earnings, Press Releases
DALLAS, Nov. 12, 2021 /PRNewswire/ -- Corporate Updates Conclusion of strategic review process with SWK to focus on specialty finance receivables business SWK evaluating ongoing dividend and additional
Enteris BioPharma Publishes White Paper on Best Practices in the Manufacturing of HPAPI Solid Oral Drug Products
2 Nov 21
Press Releases
BOONTON, N.J., Nov. 2, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK
SWK Holdings Announces Strategic Plan to Focus on Core Specialty Finance Business
1 Nov 21
Press Releases
DALLAS, Nov. 1, 2021 /PRNewswire/ -- SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small and mid-sized commercial-stage
Enteris BioPharma to Participate in the Partnership Opportunities in Drug Delivery (PODD) 2021 Conference
26 Oct 21
Press Releases
BOONTON, N.J., Oct. 26, 2021 /PRNewswire/ --Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK
Enteris BioPharma to Participate in the American Association of Pharmaceutical Scientists (AAPS) 2021 PHARMSCI 360 Conference
13 Oct 21
Press Releases
BOONTON, N.J., Oct. 13, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK